Quantitative analysis of pulmonary clearance of exogenous dopamine after cardiopulmonary bypass in humans.

The contribution of the lung to the clearance of exogenous dopamine after cardiopulmonary bypass (CPB) was analyzed quantitatively in humans and compared with the contribution of the lung before CPB. The pulmonary and arterial plasma concentration of dopamine and the pulmonary plasma flow were measured simultaneously during infusion of dopamine. Contribution of the pulmonary circulation was defined as the ratio between clearance through the pulmonary circulation and the total plasma clearance of dopamine. The calculated contribution values after CPB were 12.0, 10.7, 11.4, 16.2, and 16.7% at the doses of 3.0, 4.0, 5.0, 6.0, and 7.0 micrograms.kg-1.min-1, respectively. Those values before CPB were 15.6% and 17.4% at the doses of 1.0 and 2.0 micrograms.kg-1.min-1, respectively. The comparison of the values before and after CPB did not achieve statistical significance. Furthermore, there were no significant correlations between the pulmonary clearance after CPB and mean pulmonary arterial pressure, pulmonary vascular resistance, or CPB time. The results suggest that the pulmonary clearance mechanism for dopamine after CPB is maintained as effectively as that before CPB and is not influenced by pulmonary hypertension or CPB time.

[1]  K. Kitaguchi,et al.  Clinical evaluation of cerebral oxygen balance during cardiopulmonary bypass: on-line continuous monitoring of jugular venous oxyhemoglobin saturation. , 1992, Anesthesia and analgesia.

[2]  K. Sumikawa,et al.  Contribution of the Lungs to the Clearance of Exogenous Dopamine in Humans , 1991, Anesthesia and analgesia.

[3]  C. N. Gillis Pharmacological aspects of metabolic processes in the pulmonary microcirculation. , 1986, Annual review of pharmacology and toxicology.

[4]  C. N. Gillis,et al.  Depression of pulmonary metabolic function by cardiopulmonary bypass procedures increases levels of circulating norepinephrine. , 1984, The Annals of thoracic surgery.

[5]  Y. Ohkura,et al.  Spectrofluorimetric determination of catecholamines with 1,2-diphenylethylenediamine , 1984 .

[6]  W. J. Russell,et al.  Pulmonary Extraction of Catecholamines in Critically Ill Patients , 1982, Anaesthesia and intensive care.

[7]  C. N. Gillis,et al.  Depressed pulmonary removal of [3H]prostaglandin E1 after prolonged cardiopulmonary bypass. , 1982, Journal of applied physiology: respiratory, environmental and exercise physiology.

[8]  E. Blackstone,et al.  Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. , 1981, The New England journal of medicine.

[9]  M. Sole,et al.  The Extraction of Circulating Catecholamines by the Lungs in Normal Man and in Patients with Pulmonary Hypertension , 1979, Circulation.

[10]  N. M. Greene,et al.  Removal of 5-hydroxytryptamine and norepinephrine from the pulmonary vascular space of man: influence of cardiopulmonary bypass and pulmonary arterial pressure on these processes. , 1974, Surgery.

[11]  N. Ratliff,et al.  Pulmonary injury secondary to extracorporeal circulation. An ultrastructural study. , 1973, The Journal of thoracic and cardiovascular surgery.

[12]  N. M. Greene,et al.  Pulmonary Extraction of 5‐Hydroxytryptamine and Norepinephrine before and after Cardiopulmonary Bypass in Man , 1972, Circulation research.

[13]  J. Vane,et al.  Disappearance of Catecholamines from the Circulation , 1968, Nature.